Your browser doesn't support javascript.
loading
Efficacy and safety of electrical stimulation in the treatment of neurogenic bladder dysfunction in myelomeningocele-Systematic review of randomized clinical trials.
Silva, Tamiris; T Horliana, Anna C R; Malavazzi, Tainá C S; Santos, Elaine M; Gonçalves, Marcela L L; Fernandes, Kristianne P S; Mesquita-Ferrari, Raquel A; Martimbianco, Ana Luiza C; Bussadori, Sandra K.
Afiliação
  • Silva T; Postgraduate Program in Rehabilitation Sciences, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.
  • T Horliana ACR; Postgraduate Program in Biophotonics Applied to the Health Sciences, UNINOVE, São Paulo, Brazil.
  • Malavazzi TCS; Postgraduate Program in Biophotonics Applied to the Health Sciences, UNINOVE, São Paulo, Brazil.
  • Santos EM; Pro-rectory for Academic Affairs, UNIMES, Santos, Brazil.
  • Gonçalves MLL; Postgraduate Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos, Brazil.
  • Fernandes KPS; Postgraduate Program in Biophotonics Applied to the Health Sciences, UNINOVE, São Paulo, Brazil.
  • Mesquita-Ferrari RA; Postgraduate Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos, Brazil.
  • Martimbianco ALC; Postgraduate Program in Biophotonics Applied to the Health Sciences, UNINOVE, São Paulo, Brazil.
  • Bussadori SK; Postgraduate Program in Rehabilitation Sciences, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.
Neurourol Urodyn ; 41(1): 91-101, 2022 01.
Article em En | MEDLINE | ID: mdl-34524699
AIMS: The purpose of this systematic review was to investigate and synthesize the effects (benefits and harms) of electrical stimulation (EE), alone or in association with other interventions, compared with sham and other interventions, for the treatment of neurogenic bladder dysfunction in myelomeningocele. METHODS: This systematic review was conducted following the methodological recommendations of the Cochrane Handbook for Systematic Reviews of Interventions and registered at PROSPERO (CRD42020200425). A search was performed in the following electronic databases: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, LILACS, and PEDro. Randomized clinical trials (RCTs) that assessed any EE in children diagnosed with myelomeningocele and neurogenic bladder and/or urinary incontinence were included and reported. RESULTS: When comparing EE versus sham groups, some estimated effects showed a wide confidence interval, probably due to the small sample size of the included studies. This indicates an imprecision in these findings. Regarding the safety of this intervention and safety of the lower urinary tract, no adverse events resulting from EE were reported. All the included studies have evaluated the efficacy of EE compared with sham, but different EE parameters and electrode positions among studies make it impossible to perform a meta-analysis. CONCLUSIONS: Based on very low certainty evidence, the findings of this systematic review suggested no difference between EE and sham to improve urinary incontinence in children with myelomeningocele. However, the small sample size and the imprecision arising from the wide confidence intervals must be considered. Future RCTs following a rigorous methodology, as recommended by the CONSORT statement, should be conducted to support the use of this intervention in clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bexiga Urinaria Neurogênica / Meningomielocele Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Limite: Child / Humans Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bexiga Urinaria Neurogênica / Meningomielocele Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Limite: Child / Humans Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos